Curosurf 120mg Injection: Efficient Pulmonary Support Solution

Curosurf 120mg Injection

Active component: Poractant alfa

Indications:

• Respiratory Distress Syndrome (RDS) in premature infants.

Therapeutic effects:

• Reduces the risk of death in premature infants with RDS.
• Decreases the need for mechanical ventilation.
• Shortens the length of hospital stay.
• Effective for infants at risk of bronchopulmonary dysplasia (BPD).

Administration:

• Administered through a breathing tube into the infant's lungs (endotracheopulmonary administration).
• Should be stored at room temperature, between 2°C to 8°C.
• Keep away from moisture, heat, and light.
• Do not freeze.

Contraindications:

• Hypersensitivity to Curosurf 120mg Injection.
• Severe RDS.
• History of porcine protein hypersensitivity.
• Active bleeding.
• Neonatal pneumonia.
• Meconium aspiration syndrome.
• Not used in old age as it is ineffective in adults.

Precautions:

• Inform the doctor about all medications, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products.
• Consult a doctor before use if pregnant or planning to become pregnant.
• Safety during breastfeeding is not well established; consult a healthcare provider.
• Individuals with lung or liver disease should consult a doctor.
• Unsafe to take with alcohol.
• Driving is unsafe after receiving the injection due to potential drowsiness and dizziness.

Side effects:

• Serious: Anaphylaxis, bleeding, pulmonary hemorrhage, intracranial hemorrhage, surfactant protein B deficiency.
• Common: Bradycardia, hypotension, hypoxemia (decreased oxygen), respiratory distress, apnea, froth at the mouth, irritation at the injection site.

FAQ:

1. How long does Curosurf 120mg injection last?
   • The effects typically last for 3 to 5 days. However, some infants may need additional doses.
2. Is Curosurf 120mg injection safe for premature infants?
   • Generally considered safe, but can cause side effects such as bradycardia, hypotension, and hypoxemia.
3. What happens if my infant needs more than one dose of Curosurf 120mg injection?
   • Infants needing more than one dose may be at an increased risk of side effects, but the benefits often outweigh the risks.
4. What are the long-term risks of Curosurf 120mg injection?
   • The long-term risks are not fully known, but there is no evidence of long-term problems.
5. What is the prognosis of Curosurf 120mg injection for infants with RDS?
   • With proper treatment, most infants with RDS make a full recovery.
6. How does Curosurf 120mg injection compare to other synthetic surfactants?
   • Similar effectiveness in treating RDS, known to cause less bradycardia and hypotension than other synthetic surfactants.

Fact Box:

• Molecule name: Poractant alfa
• Therapeutic class: Pulmonary surfactants
• Pharmacological class: Surfactants
• Indications: Respiratory distress syndrome (RDS), prevention of RDS

Tags: Curosurf_120mg, Injection, Medical_drug, Pharmacology, Health_products